BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31674105)

  • 21. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
    Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
    J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival Outcomes After Portal Vein Embolization and Liver Resection Compared With Liver Transplant for Patients With Extensive Colorectal Cancer Liver Metastases.
    Dueland S; Yaqub S; Syversveen T; Carling U; Hagness M; Brudvik KW; Line PD
    JAMA Surg; 2021 Jun; 156(6):550-557. PubMed ID: 33787838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver Transplant for Nonresectable Colorectal Cancer Liver Metastases in South Africa: A Single-Center Case Series.
    Botha J; Demetriou G; Fabian J; Etheredge H
    Exp Clin Transplant; 2020 Dec; 18(7):842-846. PubMed ID: 32967602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver Transplantation as a Curative Approach for Patients With Nonresectable Colorectal Liver Metastases.
    Ahmed FA; Kwon YK; Zielsdorf S; Cooper JT; Aziz H
    Exp Clin Transplant; 2022 Feb; 20(2):113-121. PubMed ID: 35282808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
    Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
    J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
    Serrano PE; Gu CS; Moulton CA; Husien M; Jalink D; Martel G; Tsang ME; Hallet J; McAlister V; Gallinger S; Levine M
    J Surg Oncol; 2020 May; 121(6):1001-1006. PubMed ID: 32034769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
    Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
    JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors.
    Mazzaferro V; Sposito C; Coppa J; Miceli R; Bhoori S; Bongini M; Camerini T; Milione M; Regalia E; Spreafico C; Gangeri L; Buzzoni R; de Braud FG; De Feo T; Mariani L
    Am J Transplant; 2016 Oct; 16(10):2892-2902. PubMed ID: 27134017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.
    Huang YT; Park J; Chong S; Hugh TJ; Ng WL; Lin M
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e262-e270. PubMed ID: 27451967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis.
    Lei JY; Wang WT; Yan LN
    World J Gastroenterol; 2013 Sep; 19(36):6077-83. PubMed ID: 24106409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases.
    Dueland S; Smedman TM; Røsok B; Grut H; Syversveen T; Jørgensen LH; Line PD
    Transpl Int; 2021 Nov; 34(11):2205-2213. PubMed ID: 34792825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Grut H; Solberg S; Seierstad T; Revheim ME; Egge TS; Larsen SG; Line PD; Dueland S
    Br J Surg; 2018 Feb; 105(3):295-301. PubMed ID: 29168565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
    Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
    Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of 18FDG PET/CT in the management of colorectal liver metastases.
    Engledow AH; Skipworth JR; Pakzad F; Imber C; Ell PJ; Groves AM
    HPB (Oxford); 2012 Jan; 14(1):20-5. PubMed ID: 22151447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of
    Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
    Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case-matched comparison with palliative systemic therapy.
    Olthof PB; Huiskens J; Wicherts DA; Huespe PE; Ardiles V; Robles-Campos R; Adam R; Linecker M; Clavien PA; Koopman M; Verhoef C; Punt CJ; van Gulik TM; de Santibanes E
    Surgery; 2017 Apr; 161(4):909-919. PubMed ID: 28038862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by
    Grut H; Line PD; Labori KJ; Schulz A; Dueland S
    HPB (Oxford); 2022 Jul; 24(7):1055-1062. PubMed ID: 34924292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.